Evidence map›Paper›PMID 42720290›Full record

ArticleImmunity, inflammation and disease2026

RETRACTION: Vitamin D Improves Autoimmune Diseases by Inhibiting Wnt Signaling Pathway.

Abstract readRetraction Notice
In one paragraph

Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionM. Zou, Q. Song, T. Yin, H. Xu and G. Nie, "Vitamin D Improves Autoimmune Diseases by Inhibiting Wnt Signaling Pathway," Immunity, Inflammation and Disease 12, no. 2 (2024): e1192, https://doi.org/10.1002/iid3.1192. The above article, published online on 27 February 2024 in Wiley Online Library (https://onlinelibrary.wiley.com), has been retracted by agreement between the journal Editor-in-Chief, Alexander Hutchison; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation which identified discrepancies between the findings reported in the Abstract and those reported in the Results section. The investigation also identified multiple ambiguities and inconsistencies in the description of the experimental methods, including the reported dosing and experimental design, which prevent the work from being reliably interpreted and reproduced. The authors were contacted for comment and asked to provide supporting data but did not respond. Due to the nature of the concerns, the editors have lost confidence in the reliability of the findings reported in this article. The authors did not respond to the retraction notice.

Identifiers

PMID42720290
PMCPMC13560786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.